Researchers at the University of Houston, in collaboration with Baylor College of Medicine, are developing new devices for ...

The global leukemia therapeutics treatment market is expected to grow at a CAGR of 6.6% during the forecast period (2025–2035). Factors such as the rising prevalence of leukemia, increasing adoption ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Researchers have discovered genetic mutations in frequent blood donors that may promote the production of healthy cells ...

The diagnosis of leukemia relies upon a multiparametric approach involving a number of different pathology disciplines. Molecular methods are increasingly employed to help refine diagnosis ...

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.

Researchers at the University of Houston, in collaboration with Baylor College of Medicine, are developing new devices for treating children with ...